---
schema_version: "secwatch.filing_event.v1"
accession: "0001933414-25-000064"
form_type: "8-K"
ticker: "MLYS"
cik: "0001933414"
company_name: "Mineralys Therapeutics, Inc."
filed_at: "2025-05-22T23:59:59+00:00"
generated_at: "2026-05-20T18:57:40.953283+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders elect two Class II directors; ratify EY as auditor for FY2025

## Summary
- Glenn P. Sblendorio elected with 45.4M for (85.8% of votes cast) and Derek DiRocco with 45.3M for (85.6%).
- Ernst & Young ratified as independent auditor for FY2025: 59.1M for, 5.9K against, 191K abstentions.
- Over 6.3M broker non-votes on director elections; none on auditor ratification.
- Annual meeting held May 22, 2025; all proposals passed with requisite majority.

## SEC filing metadata
- accession: 0001933414-25-000064
- form_type: 8-K
- ticker: MLYS
- cik: 0001933414
- company_name: Mineralys Therapeutics, Inc.
- filed_at: 2025-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933414/000193341425000064/0001933414-25-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933414/000193341425000064/mlys-20250522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001933414-25-000064
- JSON: https://secwatch.observer/filing/0001933414-25-000064.json
- Plain text: https://secwatch.observer/filing/0001933414-25-000064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.